-
1
-
-
70349976316
-
Application of Chitosan Microspheres for Nasal Delivery of Vaccines[J]
-
10.1016/j.biotechadv.2009.06.007
-
Kang MiLan, Chong Su Cho, Han Sang Yoo. Application of Chitosan Microspheres for Nasal Delivery of Vaccines[J]. Biotechnology Advances, 2009, 27(6):857-865
-
(2009)
Biotechnology Advances
, vol.27
, Issue.6
, pp. 857-865
-
-
Milan, K.1
Cho, C.S.2
Yoo, H.S.3
-
2
-
-
0034601833
-
Improvement of the Encapsulation Efficiency of Oligonucleotide-containing Biodegradable Microspheres[J]
-
11018557 10.1016/S0168-3659(00)00299-6 1:CAS:528:DC%2BD3cXmvFOrs7o%3D
-
Freytag T, Dashevsky A, Tillman L, et al. Improvement of the Encapsulation Efficiency of Oligonucleotide-containing Biodegradable Microspheres[J]. Journal of Controlled Release., 2000, 69(1):197-207
-
(2000)
Journal of Controlled Release.
, vol.69
, Issue.1
, pp. 197-207
-
-
Freytag, T.1
Dashevsky, A.2
Tillman, L.3
-
3
-
-
2942518484
-
Sustained release veterinary parenteral products
-
DOI 10.1016/j.addr.2004.02.005, PII S0169409X04000687, Veterinary Drug Delivery: Part VI
-
Natalie J Medlicott, Niki A Waldron, Todd P Foster. Sustained Release Veterinary Parenteral Products[J]. Advanced Drug Delivery Reviews, 2004, 56(10):1 345-1 365 (Pubitemid 38748820)
-
(2004)
Advanced Drug Delivery Reviews
, vol.56
, Issue.10
, pp. 1345-1365
-
-
Medlicott, N.J.1
Waldron, N.A.2
Foster, T.P.3
-
4
-
-
0344061524
-
Development of 5-iodo-2'-deoxyuridine milling process to reduce initial burst release from PLGA microparticles
-
DOI 10.1016/S0378-5173(98)00380-9, PII S0378517398003809
-
Gèze A, Venier-Julienne MC, Mathieu D, et al. Development of 5-iodo-2′-deoxyuridine Milling Process to Reduce Initial Burst Release from PLGA Microparticles[J]. International Journal of Pharmaceutics, 1999, 178(2):257-268 (Pubitemid 29078579)
-
(1999)
International Journal of Pharmaceutics
, vol.178
, Issue.2
, pp. 257-268
-
-
Geze, A.1
Venier-Julienne, M.C.2
Mathieu, D.3
Filmon, R.4
Phan-Tan-Luu, R.5
Benoit, J.P.6
-
5
-
-
80053565703
-
Intra-articular Drug Delivery: The Challenge to Extend Drug Residence Time Within the Joint[J]
-
20947396 10.1016/j.tvjl.2010.09.019
-
Scott HR Edwards. Intra-articular Drug Delivery: The Challenge to Extend Drug Residence Time Within the Joint[J]. The Veterinary Journal, 2010, 190(1):15-21
-
(2010)
The Veterinary Journal
, vol.190
, Issue.1
, pp. 15-21
-
-
Edwards, S.H.1
-
6
-
-
2942572042
-
Issues and Challenges in Developing Long-acting Veterinary Antibiotic Formulations[J]
-
10.1016/j.addr.2004.02.009 1:CAS:528:DC%2BC3cXmtlans7s%3D 481-1 496
-
Sun Yichun, Daniel W Scruggs, Yingxu Peng, et al. Issues and Challenges in Developing Long-acting Veterinary Antibiotic Formulations[J]. Advanced Drug Delivery Reviews. 2010, 56(10):1 481-1 496
-
(2010)
Advanced Drug Delivery Reviews
, vol.56
, Issue.10
, pp. 1
-
-
Sun, Y.1
Scruggs, D.W.2
Peng, Y.3
-
7
-
-
84865328750
-
Calcium Phosphate Cements as Drug Delivery Materials[J]
-
10.1016/j.addr.2012.01.008 1:CAS:528:DC%2BC38Xkt1Cqsb8%3D 090-1 110
-
Maria-Pau Ginebra, Cristina Canal, Montserrat Espanol, et al. Calcium Phosphate Cements as Drug Delivery Materials[J]. Advanced Drug Delivery Reviews, 2012, 64(12): 1 090-1 110
-
(2012)
Advanced Drug Delivery Reviews
, vol.64
, Issue.12
, pp. 1
-
-
Ginebra, M.-P.1
Canal, C.2
Espanol, M.3
-
8
-
-
27744603432
-
Diagnosis and treatment of septic arthritis
-
DOI 10.1016/j.cveq.2005.08.001, PII S0749073905000507, New Therapies for Joint Disease
-
Alison J Morton. Diagnosis and Treatment of Septic Arthritis[J]. Veterinary Clinics of North America: Equine Practice, 2005, 21(3):627-649 (Pubitemid 41628099)
-
(2005)
Veterinary Clinics of North America - Equine Practice
, vol.21
, Issue.3
, pp. 627-649
-
-
Morton, A.J.1
-
9
-
-
34247852159
-
Chapter 88 - Synovial and Osseous Infections[M]
-
(third edition) Saunders WB Saint Louis 10.1016/B1-41-600123-9/50090-5 121-1 130
-
Robert K Schneider. Chapter 88 - Synovial and Osseous Infections[M]. Equine Surgery (third edition), Saunders WB, Saint Louis, 2006:1 121-1 130
-
(2006)
Equine Surgery
, pp. 1
-
-
Schneider, R.K.1
-
10
-
-
84869886684
-
In vitro and in vivo Evaluation of an in situ Gel Forming System for the Delivery of PEGylated Octreotide[J]
-
10.1016/j.ejps.2012.09.017
-
Laleh Erfani Jabarian, Mohammad Reza Rouini, Fatemeh Atyabi, et al. In vitro and in vivo Evaluation of an in situ Gel Forming System for the Delivery of PEGylated Octreotide[J]. European Journal of Pharmaceutical Sciences, 2013, 48(1): 87-96
-
(2013)
European Journal of Pharmaceutical Sciences
, vol.48
, Issue.1
, pp. 87-96
-
-
Jabarian, L.E.1
Rouini, M.R.2
Atyabi, F.3
-
11
-
-
45249109321
-
In vitro and in vivo Considerations Associated with Parenteral Sustained Release Products: A Review Based Upon Information Presented and Points Expressed at the 2007 Controlled Release Society Annual Meeting[J]
-
10.1016/j.jconrel.2008.04.004
-
Marilyn Martinez, Michael Rathbone, Diane Burgess, et al. In vitro and in vivo Considerations Associated with Parenteral Sustained Release Products: A Review Based Upon Information Presented and Points Expressed at the 2007 Controlled Release Society Annual Meeting[J]. Journal of Controlled Release, 2008, 29(2): 79-87
-
(2008)
Journal of Controlled Release
, vol.29
, Issue.2
, pp. 79-87
-
-
Martinez, M.1
Rathbone, M.2
Burgess, D.3
-
12
-
-
0037151423
-
Preparation of 3, 4-diaminopyridine Microparticles by Solvent-evaporation Methods[J]
-
12176246 10.1016/S0378-5173(02)00157-6 1:CAS:528:DC%2BD38Xmt1ynsrs%3D
-
Stéphane Gibaud, Aurélie Bonneville, Alain Astier. Preparation of 3, 4-diaminopyridine Microparticles by Solvent-evaporation Methods[J]. International Journal of Pharmaceutics, 2002, 242(1): 197-201
-
(2002)
International Journal of Pharmaceutics
, vol.242
, Issue.1
, pp. 197-201
-
-
Gibaud, S.1
Bonneville, A.2
Astier, A.3
|